Skip to main content
. 2022 Oct 11:M22-1856. doi: 10.7326/M22-1856

Table 3.

Risk for SARS-CoV-2–Related Hospitalization and Estimation of Vaccine Effectiveness Among Persons Who Received a Booster Dose of mRNA COVID-19 Vaccine in the VA Health Care System and Their Matched Counterparts Who Did Not Receive a Booster Dose From 1 December 2021 to 31 March 2022

Table 3. Risk for SARS-CoV-2–Related Hospitalization and Estimation of Vaccine Effectiveness Among Persons Who Received a Booster Dose of mRNA COVID-19 Vaccine in the VA Health Care System and Their Matched Counterparts Who Did Not Receive a Booster Dose From 1 December 2021 to 31 March 2022